SIGNATURE ESTATE & INVESTMENT ADVISORS LLC
Position in ROIV — Roivant Sciences Ltd.
CIK 1079935
LOS ANGELES, CA
Position in ROIV
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$6,986,658
New position
Shares Held
197,419
first reported quarter
Ownership
0.027%
of shares outstanding
% of Portfolio
0.38%
of 13F equity value
Holder Rank
#122
of 494 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Jun 30, 2026SIGNATURE ESTATE & INVESTMENT ADVISORS LLC holds $7,978,434 across 6 Biotechnology names. ROIV ranks #1 (87.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
This page
|
197,419 | $6,986,658 | |
| 2 | AXSM |
Axsome Therapeutics, Inc.
|
1,832 | $448,418 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
478 | $237,436 | |
| 4 | ONC |
BeOne Medicines Ltd.
|
737 | $210,022 | |
| 5 | ENTX |
Entera Bio Ltd.
|
47,328 | $83,770 | |
| 6 | INO |
Inovio Pharmaceuticals, Inc.
|
11,028 | $12,130 |
All Filings in ROIV
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,986,658 | 197,419 | Shares | Sole | 2026-07-14 | |
| No filing history on record for this holder in this stock. | ||||||